Alkermes plc [NASDAQ: ALKS] closed the trading session at $30.38 on 04/27/22. The day’s price range saw the stock hit a low of $29.53, while the highest price level was $31.3725. The company report on April 27, 2022 that LGBTQ+ People Are More Likely to Experience a Mental Health Condition.
Alkermes and NAMI share resources to help!.
The stocks have a year to date performance of 30.61 percent and weekly performance of 3.16 percent. The stock has been moved at -3.59 percent over the last six months. The stock has performed 10.55 percent around the most recent 30 days and changed 21.47 percent over the most recent 3-months.
If compared to the average trading volume of 1.39M shares, ALKS reached to a volume of 4158060 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Alkermes plc [ALKS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALKS shares is $29.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALKS stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Alkermes plc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 22, 2022. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on April 20, 2022, representing the official price target for Alkermes plc stock. Previously, the target price had yet another raise to $32, while Cantor Fitzgerald analysts kept a Overweight rating on ALKS stock.
The Average True Range (ATR) for Alkermes plc is set at 1.32, with the Price to Sales ratio for ALKS stock in the period of the last 12 months amounting to 4.41. The Price to Book ratio for the last quarter was 4.42, with the Price to Cash per share for the same quarter was set at 3.14. Price to Free Cash Flow for ALKS in the course of the last twelve months was 70.31 with Quick ratio for the last quarter at 1.90.
ALKS stock trade performance evaluation
Alkermes plc [ALKS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.16. With this latest performance, ALKS shares gained by 10.55% in over the last four-week period, additionally sinking by -3.59% over the last 6 months – not to mention a rise of 39.55% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALKS stock in for the last two-week period is set at 61.90, with the RSI for the last a single of trading hit 62.91, and the three-weeks RSI is set at 61.10 for Alkermes plc [ALKS]. The present Moving Average for the last 50 days of trading for this stock 26.52, while it was recorded at 28.69 for the last single week of trading, and 26.72 for the last 200 days.
Alkermes plc [ALKS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Alkermes plc [ALKS] shares currently have an operating margin of -2.50 and a Gross Margin at +78.89. Alkermes plc’s Net Margin is presently recorded at -4.10.
Return on Equity for this stock declined to -4.42, with Return on Assets sitting at -2.42.
Alkermes plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.90 and a Current Ratio set at 2.30.
Alkermes plc [ALKS]: Insider Ownership positions
There are presently around $4,303 million, or 98.80% of ALKS stock, in the hands of institutional investors. The top three institutional holders of ALKS stocks are: PRICE T ROWE ASSOCIATES INC /MD/ with ownership of 21,343,581, which is approximately 0.364% of the company’s market cap and around 1.00% of the total institutional ownership; VANGUARD GROUP INC, holding 16,891,710 shares of the stock with an approximate value of $458.44 million in ALKS stocks shares; and BLACKROCK INC., currently with $386.81 million in ALKS stock with ownership of nearly 8.89% of the company’s market capitalization.
Positions in Alkermes plc stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 113 institutional holders increased their position in Alkermes plc [NASDAQ:ALKS] by around 11,892,139 shares. Additionally, 111 investors decreased positions by around 8,936,816 shares, while 35 investors held positions by with 137,732,210 shares. The mentioned changes placed institutional holdings at 158,561,165 shares, according to the latest SEC report filing. ALKS stock had 37 new institutional investments in for a total of 1,597,488 shares, while 37 institutional investors sold positions of 2,113,451 shares during the same period.